All diseases

Disease Atlas / Disease detail

Sarcoidosis

An atlas of a multisystem granulomatous inflammatory disorder, exclusion-based diagnosis, organ surveillance, and treatment.

sarcoidosis · Besnier-Boeck-Schaumann disease

MONDO:0019338Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 53b66d1f071c

Disease class
Sarcoidosis is an inflammatory disorder that forms granulomas.
Core mechanism
Its cause is not fully understood.
Genes or cause
The lungs and chest lymph nodes are most commonly affected.
Typical features
Cough, breathlessness, and chest pain can occur.
Variability
Skin, eyes, heart, and nervous system can also be involved.
Diagnosis
Some people are asymptomatic or improve spontaneously.
Management
Diagnosis integrates symptoms, examination, imaging, and biopsy when needed.
Treatment and research
Mimics including infection and cancer are excluded.
Reading evidence
Chest imaging and lung function are assessed.
Key caution
Observation is possible when symptoms are absent and organ function is stable.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Sarcoidosis is an inflammatory disorder that forms granulomas.

Cough, breathlessness, and chest pain can occur.

How the disease works

Its cause is not fully understood.

The lungs and chest lymph nodes are most commonly affected.

Why experiences vary

Skin, eyes, heart, and nervous system can also be involved.

Diagnosis and management

Some people are asymptomatic or improve spontaneously.

Treatment status

Diagnosis integrates symptoms, examination, imaging, and biopsy when needed.

Mimics including infection and cancer are excluded.

Reading clinical trials

Treatment is tailored to involved organs and functional risk.

Topics for a clinical visit

Pulmonary, ocular, cardiac, neurologic findings and treatment toxicity require review.

Medical notice

This material is for disease education and is not a personal diagnosis or treatment instruction.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.